Coherus Oncology Inc

Penny Stocks Biotech Stocks Healthcare Stocks

$1.13

+0.00 (+0.00%)

As of Sep 28, 2:35 PM ET ·

Analyst Consensus

Strong Buy

Analysts

Moderate

Coverage

Buy 10 83%

Hold 2 17%

Sell 0 0%

Price Target

Analyst Price Target +3,103.5% upside

Low Target $24.75

Average Target $36.20

High Target $54.95

Current Price $1.13

Current
$1.13

Target
$36.20

$24.75 $36.20 avg $54.95

Scenario Analysis

Bear Case

$24.75

2,090.3%

Low target

Base Case

$36.20

+3,103.5%

Avg target

Bull Case

$54.95

+4,762.8%

High target

Risk/Reward

2.3x

Favorable

Price in Context

52-Week High

$2.62

-56.8% from high

52-Week Low

$1.09

+3.7% from low

Target vs 52W High

$36.20

+1,283.8% vs high

Peer Consensus — Biotechnology

Stock	Consensus	Analysts	Buy %	Target	Upside
ABBV Abbvie Inc	Strong Buy	39	82%	$257.58	-3.3%
AMGN Amgen Inc	Hold	43	47%	$190.87	-54.4%
GILD Gilead Sciences Inc	Strong Buy	37	81%	$362.68	+138.3%
VRTX Vertex Pharmaceuticals Inc	Strong Buy	36	81%	$438.34	-16.9%
REGN Regeneron Pharmaceuticals	Buy	38	68%	$76.80	-89.8%
MRNA Moderna Inc	Hold	30	37%	$149.45	-24.2%
NTRA Natera Inc	Strong Buy	30	87%	$142.91	-65.3%
RVMD Revolution Medicines Inc	Strong Buy	28	93%	$114.11	-43.4%